Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Engaging Multistakeholder Perspectives to Identify Patient‐Centered Research Priorities Regarding Vaccine Uptake Among Adults With Autoimmune Conditions

Engaging Multistakeholder Perspectives to Identify Patient‐Centered Research Priorities Regarding... SIGNIFICANCE & INNOVATIONSThis study brought together a multistakeholder panel from the autoimmune health community to prioritize topics related to vaccine uptake for adults with autoimmune conditions by using a well‐established methodology that allows for the identification of areas of consensus and disagreement across stakeholder groups. Decision to vaccinate is a multifaceted process that is the result of a complex series of attitudes and decision‐making actions involving a range of stakeholders; therefore, multistakeholder considerations are integral to prioritize topics.Safety and efficacy of vaccines for adults living with autoimmune conditions emerged as the highest priority topic across all stakeholder groups, with concerns that range from whether certain vaccines could cause an exacerbation of autoimmune disease to the degree to which autoimmune diseases or use of immunomodulatory therapies may blunt vaccine response.Generating high‐quality vaccine safety and efficacy data in patients with autoimmune disease and ensuring effective messaging to patients living with autoimmune conditions is critical to improving vaccine uptake and improving the health of patients.INTRODUCTIONPeople living with autoimmune diseases (eg, rheumatoid arthritis or systemic lupus erythematosus) have nearly twice the risk of acquiring severe, vaccine‐preventable infections, as well as a higher risk of serious infection‐related complications, making vaccination a high priority in http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png ACR Open Rheumatology Wiley

Loading next page...
 
/lp/wiley/engaging-multistakeholder-perspectives-to-identify-patient-centered-K554SVVCGY

References (18)

Publisher
Wiley
Copyright
© 2023 The Authors. ACR Open Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology.
eISSN
2578-5745
DOI
10.1002/acr2.11546
Publisher site
See Article on Publisher Site

Abstract

SIGNIFICANCE & INNOVATIONSThis study brought together a multistakeholder panel from the autoimmune health community to prioritize topics related to vaccine uptake for adults with autoimmune conditions by using a well‐established methodology that allows for the identification of areas of consensus and disagreement across stakeholder groups. Decision to vaccinate is a multifaceted process that is the result of a complex series of attitudes and decision‐making actions involving a range of stakeholders; therefore, multistakeholder considerations are integral to prioritize topics.Safety and efficacy of vaccines for adults living with autoimmune conditions emerged as the highest priority topic across all stakeholder groups, with concerns that range from whether certain vaccines could cause an exacerbation of autoimmune disease to the degree to which autoimmune diseases or use of immunomodulatory therapies may blunt vaccine response.Generating high‐quality vaccine safety and efficacy data in patients with autoimmune disease and ensuring effective messaging to patients living with autoimmune conditions is critical to improving vaccine uptake and improving the health of patients.INTRODUCTIONPeople living with autoimmune diseases (eg, rheumatoid arthritis or systemic lupus erythematosus) have nearly twice the risk of acquiring severe, vaccine‐preventable infections, as well as a higher risk of serious infection‐related complications, making vaccination a high priority in

Journal

ACR Open RheumatologyWiley

Published: Jun 1, 2023

There are no references for this article.